OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging
András Perl
Annals of the New York Academy of Sciences (2015) Vol. 1346, Iss. 1, pp. 33-44
Open Access | Times Cited: 201

Showing 1-25 of 201 citing articles:

Mitochondrial dysfunction and oxidative stress in aging and cancer
Anna V. Kudryavtseva, George S. Krasnov, Alexey A. Dmitriev, et al.
Oncotarget (2016) Vol. 7, Iss. 29, pp. 44879-44905
Open Access | Times Cited: 469

Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
András Perl
Nature Reviews Rheumatology (2015) Vol. 12, Iss. 3, pp. 169-182
Open Access | Times Cited: 288

Moving towards personalized treatments of immune-related adverse events
Khashayar Esfahani, Arielle Elkrief, Cassandra Calabrese, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 8, pp. 504-515
Closed Access | Times Cited: 247

Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
Rashad Hussain, Hira Zubair, Sarah Pursell, et al.
Brain Sciences (2018) Vol. 8, Iss. 9, pp. 177-177
Open Access | Times Cited: 190

Immune senescence, epigenetics and autoimmunity
Donna Ray, Raymond Yung
Clinical Immunology (2018) Vol. 196, pp. 59-63
Open Access | Times Cited: 184

mTOR Regulation of Glycolytic Metabolism in T Cells
Robert J. Salmond
Frontiers in Cell and Developmental Biology (2018) Vol. 6
Open Access | Times Cited: 172

Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine
Homam Ibrahim, András Perl, Deane E. Smith, et al.
Clinical Immunology (2020) Vol. 219, pp. 108544-108544
Open Access | Times Cited: 145

Acne vulgaris: The metabolic syndrome of the pilosebaceous follicle
Bodo C. Melnik
Clinics in Dermatology (2017) Vol. 36, Iss. 1, pp. 29-40
Closed Access | Times Cited: 166

Functional and Phenotypic Plasticity of CD4+T Cell Subsets
Tiffany Caza, Steve Landas
BioMed Research International (2015) Vol. 2015, pp. 1-13
Open Access | Times Cited: 137

mTOR: A Cellular Regulator Interface in Health and Disease
Fahd Boutouja, Christian M. Stiehm, Harald W. Platta
Cells (2019) Vol. 8, Iss. 1, pp. 18-18
Open Access | Times Cited: 126

Cancer and mTOR Inhibitors in Transplant Recipients
Johan W. de Fijter
Transplantation (2016) Vol. 101, Iss. 1, pp. 45-55
Closed Access | Times Cited: 125

PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?
Maria Luisa Gasparri, Erlisa Bardhi, Ilary Ruscito, et al.
Geburtshilfe und Frauenheilkunde (2017) Vol. 77, Iss. 10, pp. 1095-1103
Open Access | Times Cited: 124

Fasting enhances cold resistance in fish through stimulating lipid catabolism and autophagy
Dongliang Lu, Qiang Ma, Jing Wang, et al.
The Journal of Physiology (2019) Vol. 597, Iss. 6, pp. 1585-1603
Open Access | Times Cited: 118

Milk’s Role as an Epigenetic Regulator in Health and Disease
Bodo C. Melnik, Gerd Schmitz
Diseases (2017) Vol. 5, Iss. 1, pp. 12-12
Open Access | Times Cited: 110

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease
David C. Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 10, pp. 4451-4463
Open Access | Times Cited: 108

Roles of mTOR Signaling in Tissue Regeneration
Xiangyong Wei, Lingfei Luo, Jinzi Chen
Cells (2019) Vol. 8, Iss. 9, pp. 1075-1075
Open Access | Times Cited: 105

Chronic inflammation and sarcopenia: A regenerative cell therapy perspective
Jagadish K. Chhetri, Philipe de Souto Barreto, Bertrand Fougère, et al.
Experimental Gerontology (2018) Vol. 103, pp. 115-123
Closed Access | Times Cited: 99

Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives
Marta Vomero, Cristiana Barbati, Tania Colasanti, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 99

Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation
Khashayar Esfahani, Tho-Alfakar Al-Aubodah, Paméla Thébault, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 95

Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity
Takayuki Katsuyama, Hao Li, Denis Comte, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 12, pp. 5411-5423
Open Access | Times Cited: 76

Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence
Zinat Heidari, Maryam Daei, Motahareh Boozari, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 4, pp. 1442-1458
Closed Access | Times Cited: 63

T follicular helper cells in autoimmune diseases
Xindi Wei, Xiaoyin Niu
Journal of Autoimmunity (2022) Vol. 134, pp. 102976-102976
Closed Access | Times Cited: 60

Cytoplasmic DNA sensing by KU complex in aged CD4+ T cell potentiates T cell activation and aging-related autoimmune inflammation
Yan Wang, Zunyun Fu, Xutong Li, et al.
Immunity (2021) Vol. 54, Iss. 4, pp. 632-647.e9
Open Access | Times Cited: 57

Page 1 - Next Page

Scroll to top